Defense World
04 Apr 2026, 08:57 UTC · 24w ago
Verdict
Headline takes no side. We score IBDU +0.40 across two claims — moderately bullish.
+0.40moderately bullish
More positive than 65% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
JPMorgan Chase & Co. increased its stake in the iShares iBonds Dec 2029 Term Corporate ETF by 201.9%, purchasing an additional 107,010 shares to hold 160,004 shares valued at $3,755,000.
More negative than 70% of claims this week
Multiple institutional investors collectively established new positions in the iShares iBonds Dec 2029 Term Corporate ETF during Q3, with aggregate new investments totaling approximately $541,000.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 64% of claims this week
Which stocks this story touches
More positive than 65% of ticker scores this week
Multiple institutional investors, including JPMorgan, increased or initiated positions in the fund.
More positive than 54% of ticker scores this week
JPMorgan Chase & Co. acquired a new position in the company.
More negative than 66% of ticker scores this week
JPMorgan Chase & Co. trimmed its position in the fund.
Near neutral — 92% of ticker scores this week are stronger
Mentioned only as the manager of the IBDU fund.
Near neutral — 92% of ticker scores this week are stronger
The company is mentioned as performing routine portfolio rebalancing and trades.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
5h ago
More positive than 1% of relationship scores this week
[a_to_b] JPMorgan Chase & Co. acquired shares of Privia Health Group, Inc.
−2.2%
Price is moving against the score
$22.68 vs $23.20 close before publication (Apr 2) · not market-adjusted
IBDU chart →
